- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jubilant Pharmova Ltd (JUBA)
Track today's live Jubilant Pharmova (JUBA) share price, performance and key data on this page with our current NSE:JUBA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Jubilant Pharmova share price on the NSE exchange. Use the dropdown to switch exchange for the JUBA share price, head to our technical summary section, which provides analysis on Jubilant Pharmova share price buy/sell indicators using real-time data (or discuss the Jubilant Pharmova (JUBA) stock price today with other investors in the Jubilant Pharmova NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:JUBA share price (ISIN: INE700A01033) to enhance your trading decisions with our free investment tools and resources.
What Is the Jubilant Pharmova Ltd Share Price Today?
The Jubilant Pharmova share price today is 969.20.
What Is the Stock Symbol for Jubilant Pharmova Ltd
The stock symbol (or 'ticker') for Jubilant Pharmova Ltd is "JUBA."
What Stock Exchange Does Jubilant Pharmova Ltd Trade On?
Jubilant Pharmova Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Pharmova Ltd a Good Stock to Buy?
Determining whether Jubilant Pharmova (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:JUBA share price (ISIN: INE700A01033) to enhance your trading decisions with our free investment tools and resources.
What Is the Jubilant Pharmova Ltd Share Price Today?
The Jubilant Pharmova share price today is 969.20.
What Is the Stock Symbol for Jubilant Pharmova Ltd
The stock symbol (or 'ticker') for Jubilant Pharmova Ltd is "JUBA."
What Stock Exchange Does Jubilant Pharmova Ltd Trade On?
Jubilant Pharmova Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Pharmova Ltd a Good Stock to Buy?
Determining whether Jubilant Pharmova (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
969.20
-4.00(-0.41%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
963.00
979.95
52 wk Range
786.05
1,248.00
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
963.00979.95
52 wk Range
786.051,248.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.52%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.52%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JUBA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
- Jubilant Pharmova Earnings miss, Revenue beats In Q2
- Investing.com
- Jubilant Pharmova Earnings miss, Revenue beats In Q2
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
22/05/2026
EPS / Forecast
7.80 / 6.90
Revenue / Forecast
22.9B / 21.96B
Compare JUBA to Peers and Sector
Metrics to compare | JUBA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJUBAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.7x | 30.5x | −0.4x | |
PEG Ratio | −0.74 | 0.70 | 0.00 | |
Price/Book | 2.2x | 3.4x | 2.6x | |
Price / LTM Sales | 1.9x | 3.7x | 3.0x | |
Upside (Analyst Target) | 17.0% | 7.5% | 50.7% | |
Fair Value Upside | Unlock | 7.3% | 6.5% | Unlock |
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Jubilant Pharmova (NSE: JUBA) Share Price Today?
The Jubilant Pharmova stock price today is 969.20 INR.
What Stock Exchange Does Jubilant Pharmova (JUBA) Trade On?
Jubilant Pharmova is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Jubilant Pharmova?
The stock symbol (also called a 'ticker') for Jubilant Pharmova is "JUBA."
Does Jubilant Pharmova Pay Dividends? What’s The Current JUBA Dividend Yield?
Yes, JUBA Pays Dividends to its Shareholders. The current Jubilant Pharmova dividend yield is 0.52%.
What Is the Current Jubilant Pharmova Market Capitalisation?
As of today, Jubilant Pharmova (NSE: JUBA) market cap is 153.45B INR.
What Is Jubilant Pharmova's (JUBA) Earnings Per Share (TTM)?
The Jubilant Pharmova EPS is currently 25.08 (Trailing Twelve Months).
When Is the Next Jubilant Pharmova Earnings Date?
Jubilant Pharmova's next earnings report will be released on 17/07/2026.
Is JUBA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Jubilant Pharmova moving averages and other technical indicators, the daily buy/sell signal for JUBA stock is Strong Sell.
How Many Times Has Jubilant Pharmova Stock Split?
Jubilant Pharmova has split 1 times. (See the JUBA stock split history page for full effective split date and price information.)
How Many Employees Does Jubilant Pharmova Have?
Jubilant Pharmova has 5547 employees, based on their latest Companies House report.
What is the current trading status of Jubilant Pharmova (NSE: JUBA)?
As of 03/07/2026, Jubilant Pharmova (JUBA) is trading at a share price of 969.20 INR, with a previous close of 973.20 INR. The stock has fluctuated within a day range of 963.00 INR to 979.95 INR, while its 52-week range spans from 786.05 INR to 1,248.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.